Adjuvant chemotherapy guided by a 21-gene expression assay has been proved in breast cancer.24 We did not analyze the status of some well-known gene mutations, such as BRCA1/2 and RAD51C/D. This evidence concerns the gene RAD51C and breast carcinoma.